Abiopharma

New Form 8-K - MEI Pharma, Inc. Filed: 2025-07-22 AccNo: 0001140361-25-026773 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of …

New Form SC 14D9/A - Verve Therapeutics, Inc. Filed: 2025-07-22 AccNo: 0001193125-25-162672 Size: 16 KB

New Form 6-K - Abivax S.A. Filed: 2025-07-22 AccNo: 0001193125-25-162671 Size: 105 KB

New Form SC TO-T/A - Verve Therapeutics, Inc. Filed: 2025-07-22 AccNo: 0001193125-25-162670 Size: 22 KB

New Form SCHEDULE 13D/A - Biomea Fusion, Inc. Filed: 2025-07-22 AccNo: 0000929638-25-002664 Size: 12 KB

New Form 8-K - Cingulate Inc. Filed: 2025-07-22 AccNo: 0001641172-25-020618 Size: 841 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits

New Form S-1 - Lyra Therapeutics, Inc. Filed: 2025-07-22 AccNo: 0001193125-25-162669 Size: 606 KB

New Form 4 - MADRIGAL PHARMACEUTICALS, INC. Filed: 2025-07-22 AccNo: 0001628280-25-035583 Size: 9 KB

New Form 4 - MADRIGAL PHARMACEUTICALS, INC. Filed: 2025-07-22 AccNo: 0001628280-25-035580 Size: 9 KB

New Form DEFA14A - TITAN PHARMACEUTICALS INC Filed: 2025-07-22 AccNo: 0001641172-25-020611 Size: 6 MB